Health Technology Assessment Conference 2013

KEYNOTE SPEAKERS INCLUDE:

> Medical Benefits Division, Department of Health and Ageing - Speaker to be Confirmed

> Robyn Ward, Chair, Medical Services Advisory Committee (MSAC), Department of Health and Ageing

> Ruth Lopert, Principal Adviser Market Authorization, Therapeutic Goods Administration (TGA), Department of Health and Ageing

> Brendon Kearney, Chair, HealthPACT and Site Clinical Director, Royal Adelaide Hospital

> Anne Kolbe, Chair, National Health Committee New Zealand

> Faye Sumner, Chief Executive Officer, Medical Technology Association of New Zealand

> Adam Elshaug, Principal Research Fellow, Menzies Centre for Health Policy, The University of Sydney

> Peggy McBride, Health Economics and Outcomes Manager, Medtronic Australasia Pty Ltd.

A COMPREHENSIVE PROGRAM ADDRESSING:

> Policy, Standards and Guidelines

> Reforms To The Regulation Of Pharmaceuticals

> Exploring Innovative Approaches To HTA For Medical Procedures And Diagnostics

> Disinvestment Decision Making

> HTA Case Studies: Decision Making in Hospital Based Organisations

> Community Engagement in HTA

> Ethics and HTA

> Evidence for HTA

> HTA Methodology: Meeting Challenges and Adjusting Evaluation

INTERACTIVE PANEL DISCUSSIONS:

> Choosing The Right Assessment Method For Non-Drug Technologies: Observational Studies vs. Randomised Control Trials (RCT)

> Incorporating Ethics and Community Perspectives Into HTA In Australia: What Are The Drivers For And Barriers To Incorporating These Perspectives?

PRE-CONFERENCE WORKSHOP: WEDNESDAY 4TH DECEMBER 2013 9am - 5pm

Understanding The Australian Co-Dependent Technology Evaluation Framework When Applied To Personalised Medicines And Companion Diagnostic Tests.